Abstract Body

Ending the HIV Epidemic (EHE) calls for rapid treatment of HIV to achieve viral suppression (VS), as one way to curb new HIV infections. Rapid initiation of ART is now recommended by all major HIV guidelines. Rapid initiation of ART is critical in the American South, where barriers to care entry and ART initiation are disproportionately high. We describe time to VS trends in a predominately Black, un- and underinsured population of ART-naïve persons with HIV (PWH) entering care since the implementation of Rapid ART in an urban, EHE jurisdiction clinic.

We examined ART-naive, adult PWH new to HIV care (e.g. detectable viral load at clinic entry and no self report of prior ART) at an HIV clinic in Atlanta, GA who enrolled in care between 2016-2020. We calculated time to first undetectable HIV viral load (<2.3 log-copies/mm3) and frequency statistics for demographic variables by year of enrollment. Kaplan-Meier survival and Cox proportional hazards analysis were used to assess temporal trends in time to first undetectable viral load, adjusting for sex, race, and HIV risk factor.

Among 688 ART-naive PWH enrolled in care, 77.3% were males, 85% were Black, 7% were Hispanic, 69% were aged 18-39, 54% were men who have sex with men, 41% reported current or former substance use, and there was a median annual income of $15,600. The median CD4 at enrolling was 250 cells/mL (IQR 362 cell/mL), with 53.7% <200 and 33.6% <50, and the median HIV viral load (VL) was 4.51 log-copies/mL (IQR 1.94 log-copies/mL). 74.71% of the cohort obtained an undetectable VL during follow up. The overall median time from enrollment to first undetectable viral load was 61 days (IQR: 34, 155). From 2016-17 to 2018-19, the median time from enrollment to first undetectable VL decreased by 40% from 62 days (IQR 146) to 37 days (IQR 56 days) (Kaplan-Meier Log-Rank p<0.05). Moreover, Cox hazard analysis revealed those in 2018-19 obtained a first undetectable viral load 1.399 (1.035, 1.891, p<0.05) times more quickly than those 2016-17, after adjusting for sex, race, income, and age.

Time to first VS improved over time after initial implementation of Rapid ART in this clinical setting. Improved clinical outcomes over time mirrored clinic-wide increases in funding and implementation infrastructure. While further analysis is needed to determine persistence of VS among these patients, these trends in decreasing time to initial VS indicate progress toward EHE even in one of the hardest hit regions.